You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 140 No. 2, February 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (15)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Hypersensitivity
 •Drug Therapy
 •Adverse Effects
 •Alert me on articles by topic

Is a Drug Alone Sufficient to Cause the Drug Hypersensitivity Syndrome?

Arch Dermatol. 2004;140:226-230.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

DRUG HYPERSENSITIVITY SYNDROME (DHS) can be defined as the clinical triad of fever, rash, and internal organ involvement due to drug exposure.1 Other groups use the term drug rash with eosinophilia and systemic symptoms (DRESS) to describe the same syndrome.2 Although the preferred nomenclature of the syndrome is debatable, the clinical features comprising the syndrome are agreed upon. The exact pathogenesis of this syndrome remains unknown, although several hypotheses have been proposed.1, 3-5 Clearly, drug exposure is a key factor in the etiology of these reactions. However, is a drug alone sufficient to cause DHS?

The pathophysiological mechanisms involved in the evolution of DHS are likely to represent a complex interaction between numerous constitutional and acquired factors resulting in a diverse clinical presentation. The association of viral infections and adverse drug reactions is illustrated by 2 well-known examples: the high incidence of skin eruptions in patients with infectious mononucleosis who are . . . [Full Text of this Article]

Gavin A. E. Wong, MBChB, MRCP(UK)
Toronto

Neil H. Shear, MD, FRCPC
Divisions of Dermatology and Clinical Pharmacology
University of Toronto
Sunnybrook & Women's College Health Sciences Centre
2075 Bayview Ave
Toronto, Ontario, Canada M4N 3M5
(e-mail: Neil.Shear@sw.ca)


RELATED ARTICLE

Association Between Anticonvulsant Hypersensitivity Syndrome and Human Herpesvirus 6 Reactivation and Hypogammaglobulinemia
Yoko Kano, Miyuki Inaoka, and Tetsuo Shiohara
Arch Dermatol. 2004;140(2):183-188.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Toxic Epidermal Necrolysis Due to Zonisamide Associated With Reactivation of Human Herpesvirus 6
Teraki et al.
Arch Dermatol 2008;144:232-235.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.